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Emerging longitudinal research has highlighted poor sleep as a risk factor of a range of adverse health
outcomes, including disabling pain conditions. In establishing the causal role of sleep in pain, it remains to
be clariﬁed whether sleep deterioration over time is a driver of pain and whether sleep improvement can
mitigate pain-related outcomes. A systematic literature search was performed using PubMed MEDLINE,
Ovid EMBASE, and Proquest PsycINFO, to identify 16 longitudinal studies involving 61,000 participants.
The studies evaluated the effect of sleep changes (simulating sleep deterioration, sleep stability, and sleep
improvement) on subsequent pain-related outcomes in the general population. A decline in sleep quality
and sleep quantity was associated with a two- to three-fold increase in risk of developing a pain con-
dition, small elevations in levels of inﬂammatory markers, and a decline in self-reported physical health
status. An exploratory meta-analysis further revealed that deterioration in sleep was associated with
worse self-reported physical functioning (medium effect size), whilst improvement in sleep was asso-
ciated with better physical functioning (small effect size). The review consolidates evidence that changes
in sleep are prospectively associated with pain-related outcomes and highlights the need for further
longitudinal investigations on the long-term impact of sleep improvements.
© 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
There is increasing epidemiological evidence highlighting sleep
deﬁcits and disturbances as risk factors of poor physical health [1,2]
and mental well-being [3,4]. Sleep problems have been speciﬁcally
linked to the development of chronic pain, which refers to pain that
persists beyond the expected time of healing from injury, illness or
tissue damage (3e6 mo) [5,6]. Unlike acute pain that serves the
important function of signalling harm to the body's integrity,
chronic pain is in itself a disease with poor prognosis, featuring
peripheral and central sensitisation to pain signals in the absence of
clear underlying pathology [7,8]. Despite its invisible nature,
chronic pain e like insomnia e can considerably limit one's day-to-gy, University of Warwick,
gy, University of Warwick,
olalu), n.tang@warwick.ac.uk
Ltd. This is an open access article u
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with exploratory meta-anday functioning; from concentrating on a task, to walking, sleeping,
maintaining social relationships, and holding down a job for in-
dependent living [9]. In primary care, chronic pain is ranked the top
cause of quality-adjusted life-year loss, surpassing cardiovascular
disease, high blood pressure, mood and anxiety disorders, diabetes,
and common respiratory conditions [10]. Considering the high
prevalence of both insomnia symptoms (10e30%; [11e13]) and
chronic pain (10e20%; [9,14]) in the general population and their
potency to impair well-being, the frequent co-occurrence of sleep
and pain presents a serious public health challenge to our ageing
society [15e17].
Evidence for the effect of sleep problems on pain from micro-
longitudinal studies
Conventionally, sleep disturbance is thought to be a symptom
secondary to pain and the two conditions are assumed to be
broadly bi-directionally linked. However, recent research has been
able to show that sleep problems may have a stronger contributory
effect on pain than the effect of pain on sleep, shifting the researchnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
nges on pain-related health outcomes in the general population: A
alysis, Sleep Medicine Reviews (2017), http://dx.doi.org/10.1016/
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E.F. Afolalu et al. / Sleep Medicine Reviews xxx (2017) 1e162emphasis onto the temporal association from sleep to pain [18,19].
Much of the evidence on the temporal impact of sleep on subse-
quent pain has come from longitudinal studies. Micro-longitudi-
nal studies as described by Afﬂeck et al. [20] use ‘time-series’
designs to examine day-to-day sleep and pain variations in in-
dividuals over a period of one to two weeks. These studies have
shown that night-time sleep parameters more consistently predict
next-day pain compared to pain predicting subsequent sleep.
Edwards et al. [21] found evidence to support a close link between
sleep and pain on a day-to-day basis. In their sample of 971 healthy
adults assessed over the telephone for a week, self-reported sleep
duration the previous night was a signiﬁcant predictor of pain
symptoms frequency the next day. Whilst pain symptoms did in
turn predict subsequent sleep duration, the magnitude of the effect
was only half as strong as the inﬂuence of sleep duration predicting
pain.
Tang et al. [22] monitored sleep and pain reports over a week in
a sample of 119 mixed chronic pain patients in their natural living
and sleeping environments, using actigraphy and electronic daily
diaries to assess sleep, pain, and mood reports at three time points
over the course of the day. Results from multilevel modelling
indicated that sleep quality was a signiﬁcant and consistent pre-
dictor of next day pain at all assessment points. In contrast, whilst
presleep pain was a predictor of poorer sleep efﬁciency calculated
based on sleep diary entries, it was not a signiﬁcant predictor of
subsequent sleep efﬁciency as estimated by actigraphy. Compared
to pain, presleep cognitive arousal andmoodwere better predictors
of subsequent sleep.
Evidence for the effect of sleep problems on pain frommacro-
longitudinal studies
There are somemacro-longitudinal (prospective) studieswith
less frequent assessments but longer timeframes that have exam-
ined the prevalence and incidence of insomnia and chronic pain at
the population level. These studies have found evidence that poor
sleep is a primary factor predicting aggravation of pain responses
and determining longer-term risks of developing a pain condition.
Mork and Nilsen [23] demonstrated in a sample of 12,350 healthy
women that incidence of self-reported sleep problems tripled the
risk of reporting physician-diagnosed ﬁbromyalgia 11 y later. The
analyses were adjusted for age, general physical health status, and
psychological wellbeing, with the resultant risk increasing
depending on the frequency and severity of sleep problems. Gupta
et al. [24] and McBeth et al. [25] also reported that poor self-
reported sleep quality strongly predicted the onset of widespread
pain symptoms up to 3 y later, even when other psychological,
lifestyle, and health factors were all controlled for. Similarly, Nitter
et al. [26] found that self-reported disrupted and non-restorativePlease cite this article in press as: Afolalu EF, et al., Effects of sleep cha
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j.smrv.2017.08.001sleep were signiﬁcant predictors of chronic pain onset in pain-
free individuals over the course of 17 y. The same sleep predictors
also increased the risk of pain persistence and worsening among
those who already had chronic pain at baseline. Despite not having
intensive repeated assessments of sleep, ﬁndings from these pro-
spective studies have shed light on the potential long-term impact
of sleep on pain.
Focussing on the long-term impact of changes in sleep on pain
outcomes
That said, the causality of the relationship between sleep and
pain needs ﬁner characterisation. Whilst it is understood that sleep
patterns and sleep quality ﬂuctuate over time, little is known about
the effect of these sleep changes on pain and other health variables
in the long run. This is in part due to the fact that many macro-
longitudinal studies examined sleep statically at a certain time
point rather than studying the dynamic changes in sleep across
multiple assessment points. Further research using repeated mea-
surements of sleep disturbances would help establish whether
greater or lesser exposure to sleep problems over time leads to
changes in incidence of pain and related symptoms [27,28].
Macro-longitudinal studies also often do not have suitable de-
signs and assessment technologies to explore the processes un-
derpinning sleep changes. In experimental studies, acute sleep
restriction in healthy pain-free participants in the form of 88-h total
sleep deprivation [29] and partial sleep deprivation of 6 h a night
over a week [30] or 4 h a night over 10 d [31] were associated with
impaired immunity, elevated inﬂammatory response and raised
cytokines levels, namely, interleukin-6 (IL-6), C-reactive protein
(CRP), cortisol, prostaglandin E2 (PGE2), and tumour necrosis factor
alpha (TNF-a). These biomarkers are also believed to be related to
greater self-reported pain, pain sensitivity, fatigue, and consequent
decline in self-reported health status [32]. However, the use of
measures that assess these biomarkers is sporadic in longitudinal
studies and as such their roles in inﬂuencing the impact of sleep
changes on long-term pain outcomes require conﬁrmation. Finally,
it should be mentioned that, of the few studies that examined
change in sleep, the focus of analysis is primarily on the effects of
negative rather than positive changes. It would be important to
verify whether improvement in sleepe outside of clinical trialse is
also associated with improvement in pain-related health outcomes.
Aims of the current systematic review
Given the above considerations, the present review examined
prospective (macro-longitudinal) studies that have assessed
improvement and deterioration in sleep over time and the inﬂu-
ence of these changes on subsequent pain-related outcomes. Thenges on pain-related health outcomes in the general population: A
alysis, Sleep Medicine Reviews (2017), http://dx.doi.org/10.1016/
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state of the research, ii) critically assess the methodological quality
of and consistency in ﬁndings across existing studies, and iii) carry
out an exploratory meta-analysis to quantify the effect of changes
in sleep on self-reported health outcome over time.
The predicting/exposure variable was deﬁned as changes in
sleep parameters e.g., insomnia symptoms, sleep quantity, and
sleep quality. To gain a clearer idea of how different sleep measures
inﬂuence pain, ﬁndings were separated by different pain-related
health outcomes. These outcomes were not only limited to diag-
nosis of the pain condition itself, but also included pain-related
physiological status such as inﬂammation/immune functions and
self-reported health status (Refer to Fig. 1 for a schematic ﬁgure
summarising this approach, and the methodologies of included
studies). We acknowledge that factors such as anxiety and
depression may play an important role in changes in sleep and
subsequent health outcomes. However, since they were not the
focus of this review, we refer readers to Alvaro et al. [33] and
Lustberg and Reynolds [34] for comprehensive reviews on these
topics.
Methods
Data source and search strategy
The data source for this systematic review was original longi-
tudinal studies that have evaluated the effect of prospective
changes in sleep on pain-related health outcomes. Relevant articles
were identiﬁed through electronic searches performed usingFig. 1. Summary of the framework underlying this systematic review and methodo-
logical design of the included studies. Based on the experimental and epidemiological
evidence, the ﬁgure illustrates the potential prospective relationship between changes
in sleep and chronic pain experience. Changes in sleep from baseline to follow-up
represents the variable predicting subsequent chronic pain experience. Change in
sleep* refers to change in i) sleep duration, ii) sleep quality, and/ or iii) insomnia
symptoms. Pain-related health outcomes# represents the factors that make up overall
pain experience, namely, the risk of developing a pain condition, changes in physio-
logical inﬂammatory and immune processes and changes in self-reported pain-related
health and functioning status.
Please cite this article in press as: Afolalu EF, et al., Effects of sleep cha
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j.smrv.2017.08.001PubMed MEDLINE, Ovid EMBASE, and ProQuest PsycINFO. Refer-
ence lists of included studies and relevant reviews were also hand-
searched to ensure comprehensive coverage. The protocol of this
systematic review has been reviewed and registered with PROS-
PERO, an international prospective register of systematic reviews.
The PROSPERO registration number is 2015:CRD42015023943.
The initial search was carried out by EA in June 2015 and
repeated just before the ﬁnal analysis (April 2017) to provide an
update. Searches were carried out on each database using both
study subject (sleep*OR insomnia) AND study methodology (lon-
gitudinal OR prospective) search terms in the title and abstract
ﬁelds. There was no restriction on publication year, but ﬁlters were
set limiting the search to human studies and in the English lan-
guage. Given that a broad array of measures can be used to index
pain-related health outcomes, no restriction was set to limit the
search by outcomes reported. This approach returned a large vol-
ume of potentially eligible articles. Whilst the screening process
was laborious for the review team, it was considered a more
comprehensive and inclusive method to capture all relevant
studies.
Screening
Due to the large volume of hits returned, the ﬁrst round of
screening was a “title” screen carried out by EA to screen for un-
related articles, animal studies, studies in children populations and
in critically ill/hospitalised patients. This resulted in a number of
irrelevant articles being eliminated. The next step was an eligibility
assessment of both titles and abstracts and involved four re-
searchers (FR, SA, NK, and PC e a doctoral student and three un-
dergraduate students) from the review team, all of whom had been
given training and detailed guidance on the screening procedure.
They did the screening collaboratively using an eligibility checklist
to identify relevant studies. The screening checklist included six
questions requiring a ‘yes’ or ‘no’ response. Each question reﬂects
each of the inclusion criteria (see Table 1). Only studies with a ‘yes’
response to questions 1, 2, 4, 5 and 6 and a ‘no’ response to question
3 were included for full-text screening. The title and abstract screen
was cross-checked by EA, differences in opinion among the re-
viewers were resolved through team discussion. The discussion
erred on the side of caution to include studies for further full-text
screening even if there were doubts on study eligibility based on
response to the six questions. A total of 14 studies required further
extensive discussion on eligibility. Interrater agreement rate
(Cohen's Kappa) between reviewers and EA was 0.77, a value
considered ‘good’ [35].
Study selection
Fig. 2 (ﬂow diagram) depicts the search and screening process.
After the initial title and abstract screen, 44 articles were selectedTable 1
Screening criteria questions.
1. Is the study an original article in the English language? (i.e., not a secondary
analysis or a review paper) “Yes” to include
2. Is the study population in human/adults (over 18 y)? “Yes” to include
3. Is the study of sleep conducted within the context of sleep disorders, drug
trials, psychological therapy, medical illness/hospitalised patients*,
circadian rhythm disorders or shift work? “No” to include
4. Does the study report a change in sleep or a measure of sleep on at least two
occasions? “Yes” to include
5. Is the study design longitudinal? “Yes” to include
6. Does the study include an outcome measure of health? “Yes” to include
Note: *This excluded studies carried out on acutely ill and hospitalised medically ill
or psychiatric patients but did not exclude populations within the general com-
munity with other pain or medical conditions.
nges on pain-related health outcomes in the general population: A
alysis, Sleep Medicine Reviews (2017), http://dx.doi.org/10.1016/
Fig. 2. Flowchart of study selection.
E.F. Afolalu et al. / Sleep Medicine Reviews xxx (2017) 1e164for full-text screening. The full texts of these studies were then
assessed for eligibility by EA as per the inclusion criteria, using the
same aforementioned screening checklist, but with further
emphasis on the following qualities: i) the study had to have a
prospective follow-up design, ii) that reported a change in sleep
parameters using a measure of sleep, iii) on at least two occasions
(baseline and follow-ups) and iv) that the association of change in
sleep with a subsequent pain-related outcome was reported (See
Fig. 1).
Following the full-text screening, 28 studies were excluded
because they did not meet all the inclusion criteria. Most werePlease cite this article in press as: Afolalu EF, et al., Effects of sleep cha
systematic review of longitudinal studies with exploratory meta-an
j.smrv.2017.08.001excluded as they only assessed sleep at baseline, did not report an
analysis of change in sleep or sleep was not the main exposure or
predicting variable. Sixteen studies met the full inclusion criteria
and were selected for data extraction and data synthesis. All
screened full-text articles and included studies were cross-checked
for eligibility by a senior member of the review team (NT).
Predicting and outcome variables
The predicting variable was ‘change in sleep’ and outcome
variable was ‘pain-related health outcomes’. ‘Change in sleep’ wasnges on pain-related health outcomes in the general population: A
alysis, Sleep Medicine Reviews (2017), http://dx.doi.org/10.1016/
E.F. Afolalu et al. / Sleep Medicine Reviews xxx (2017) 1e16 5deﬁned as change in any sleep parameters assessed in the study
between two time points, e.g., change in sleep quantity, sleep
quality, and/or insomnia symptoms. Change in sleep was derived
from the difference in sleep at follow-up compared to sleep at
baseline. ‘Pain-related health outcomes’ was operationalised as
measures indicative of any pain conditions and/or pain symptoms.
This included incidence or presence of pain-related health condi-
tions (back pain, ﬁbromyalgia, arthritis, hip fractures etc.), inﬂam-
matory and immune system biomarkers, pain intensity, pain
interference, fatigue, pain-related psychosocial functioning, and
quality of life. This diverse deﬁnition of pain-related health
outcome covered different dimensions of the chronic pain experi-
ence and can be grouped into those representing i) the diagnosis
(given by health care professionals), ii) the physiological underlying
factors (indicated by relevant biomarkers) and iii) individuals' self-
reported health-related perceptions and judgements (reﬂected by
responses to questionnaires).
Data extraction
Characteristics of the included studies are presented in Table 2
which summarises the extracted details on study methodology
(i.e., ﬁnal sample size at follow-up, participants' characteristics,
sleep assessment measure, outcome assessment measure, number
of follow-up assessments and duration of follow-up, adjusted var-
iables, and main results on the effect of changes in sleep on
outcome measure). For studies with multiple outcome measures,
the main results included in this review were those related spe-
ciﬁcally to the effect of change in sleep on a pain-related health
outcome. When the relevant information was missing or not re-
ported in the preferred formats in the original paper, the corre-
sponding author of the article was contacted by email, with another
follow-up email sent after three weeks if no response. Requests
were sent out requesting additional information for seven [36e42]
of the included articles. Five authors responded and three
[36,40,42] were able to provide the requested information.
Risk of bias assessment
Risk of bias was assessed qualitatively using a checklist adapted
from: the strengthening the reporting of observational studies in
epidemiology (STROBE) guidelines for reporting observational
epidemiological studies [43] and the modiﬁed agency for health-
care research and quality (AHRQ) quality assessment criteria for
observational studies [44]. All included studies were assessed for
risk of bias using four categories: i) methods of selecting and
assessing study participants, ii) measurement methods, iii) design-
speciﬁc issues (attrition and confounders), and iv) statistical anal-
ysis methods (see Fig. 3 for description of each category and the
corresponding studies). This descriptive approach to risk of bias
assessment provides details on the direction and magnitude of bias
across the different methodological domains relevant to the study
design and conduct. This approach has been used in other sys-
tematic reviews [45,46] and follows the recommendation of the
Cochrane collaboration [47], which advises against the use of
summary scores and quality scales.
Data synthesis and analysis
All included studies were synthesised in a narrative form,
organised by outcome and presented under three subsections: i)
change in sleep and risk of developing pain condition, ii) change in
sleep and inﬂammatory or immune function biomarkers, and iii)
change in sleep and self-reported pain-related health status. The
primary aim of the systematic reviewwas a narrative review but wePlease cite this article in press as: Afolalu EF, et al., Effects of sleep cha
systematic review of longitudinal studies with exploratory meta-an
j.smrv.2017.08.001were able to pool together a subset of the studies reporting the
physical component summary (PCS) score from the short form
health survey-36 (SF-36) as a measure of pain-related health status
for an exploratory meta-analysis. The SF-36 [48] is a validated
measure of health-related quality of life and gives two summary
scores: mental component summary (MCS) and physical compo-
nent summary (PCS). For this review, wewere interested in the PCS
score which provided a composite score that is a combination of
four of the SF-36 subscales (physical functioning, physical role
functioning, bodily pain, and general health). Data were available
from the three studies which assessed PCS as an outcome measure
[40,41,49] and these were included as part of the exploratory meta-
analysis to compare differences between effects of sleep change
over time on self-reported physical health status.
For the meta-analysis, means and standard deviations of rele-
vant outcome (PCS scores) were extracted for the individuals with
no change or with change in sleep over the follow-up period.
Change in sleep was a change in the reporting of sleep status at
follow-up compared to the reported sleep status at baseline.
Standardised mean differences (SMD) between those with change
and those with no change in sleep were estimated using a random
effect model. A similar method was used for an additional analysis
comparing the PCS scores between persistent poor sleepers (i.e., no
change in poor sleep between two time points) and persistent good
sleepers (i.e., no change in good sleep between two time points).
Statistical heterogeneity among the studies was assessed using the
I2 statistic along with visual inspection of the forest plot. Sensitivity
analysis was carried out when a meta-analysis showed signiﬁcant
heterogeneity (I2 >50%) and involved omitting one study at a time
to reveal the potential source of heterogeneity. All statistical anal-
ysis was performed using RevMan 5 [50].
Results
Demographic characteristics of included studies
The 16 prospective cohort studies included involved a total of
61,100 participants (female %: 50e100%; mean age: 30e80þ y)
from 10 different countries (USA ¼ 6, UK ¼ 2, Israel, Sweden, Japan,
Canada, Hong Kong, Finland, Korea and Singapore) and recruited
from the community. The length across these longitudinal studies
ranged from 1 mo to 23 y, with a median follow-up period of 4.5 y.
Measures of sleep changes
Most studies assessed sleep twice, once at baseline and once at
follow-up, except for four studies [38,41,51,52] that assessed sleep
at three time points. Sleep was primarily assessed using self-report.
Five of the studies [41,42,53e55] assessed self-reported insomnia
symptoms (difﬁculty falling asleep, difﬁculty maintaining sleep,
early morning awakenings, symptoms of impaired daytime func-
tioning, concern about not getting enough sleep and daytime
sleepiness) and other similar general indicators of non-restorative
sleep. Parthasarathy et al. [56] assessed these insomnia symptoms
based on deﬁnitions derived from the International classiﬁcation of
sleep disorders insomnia diagnostic criteria. Agmon and Armon [51]
used a validated questionnaire (Athens insomnia scale) to assess
insomnia symptoms. Three studies used validated questionnaires,
e.g., the Pittsburgh sleep quality index (PSQI) [37,49] and the Jen-
kins sleep questionnaire [52], to index sleep quality. Four studies
[36,38,39,57] assessed changes in sleep quantity by asking self-
reported sleep duration at baseline and follow-up. One study [58]
assessed sleep using both self-reported sleep quality and sleep
quantity. Only one study [40] used both self-report and overnight
polysomnography (PSG) to assess sleep. However, in this study, PSGnges on pain-related health outcomes in the general population: A
alysis, Sleep Medicine Reviews (2017), http://dx.doi.org/10.1016/
Table 2
Study characteristics.
Citation
Country
Final sample
Gender
Mean age
(ﬁnal sample)
Ethnicity
Predicting variable Pain-related health
outcome
Follow-up
duration
Timing of assessments Adjusted variables Results: sleep deterioration Results: sleep
improvement
Agmon & Armon
(2014) [51]
Israel
N ¼ 2131
66% male
46.20 y
not stated
Change in self-reported
insomnia symptoms from
Athens insomnia scale.
Diagnosis of back pain
(conﬁrmed through
medical records and
medical interview with
physician)
3.7 y Predicting variable and
pain-related health
outcome assessed at
three time points
spread over a period of
3.7 y.
Age, gender, education,
physical activity, self-rated
health, smoking, BMI, levels
of high-sensitivity C-
reactive protein.
Increase in insomnia
symptoms from time 1 to
time 2 was associated with
increased risk of diagnosis
of back pain at Time 3
(OR ¼ 1.40 94% CI 1.10
e1.71).
None reported.
Campbell et al.
(2013) [52]
UK
N ¼ 2622
42.1% male
Not stated
range 50e80þ y
not stated
Change in self-reported
sleep quality (Jenkins sleep
questionnaire).
Self-reported pain
presence, persistence,
interference and
depressive symptoms.
6 y Predicting variable and
pain-related health
outcome assessed at
three time points
(baseline, 3 y and 6 y).
Age, gender, alcohol
consumption, smoking,
marital status, employment
status, and BMI.
New onset of sleep
problems associated with
increased pain interference
and increased risk of
depression at follow-up.
None reported.
Ferrie et al. (2013) [36]
UK
N ¼ 5003
71.8% male
49.3 y
not stated
Change in self-reported
sleep quantity.
Immune marker e CRP
and IL-6 levels.
5 y Predicting variable and
pain-related health
outcome assessed at
two time points
(baseline and follow-
up).
Age, gender, occupation,
systolic blood pressure,
BMI, total cholesterol, and
diabetes.
Decrease in sleep quantity
signiﬁcantly associated
with higher IL-6 levels but
not CRP at follow-up.
Increase in sleep
quantity not
signiﬁcantly associated
with CRP and Il-6 levels
at follow-up.
Foley et al. (1999) [53]
USA
N ¼ 6899
62% male
Not stated
aged 65þ y
not stated
Change in self-reported
insomnia symptoms
(difﬁculty falling asleep or
early morning arousal).
Diagnosis of hip
fracture by physician.
3 y Predicting variable and
pain-related health
outcome assessed at
two time points
(baseline and follow-
up).
Age, gender, community
(state of residence), income,
and education.
New incidence and
persistence of insomnia
symptoms signiﬁcantly
associated with newly
reported presence of hip
fracture at follow-up
(OR ¼ 2.08 95% CI 1.18,
3.65).
None reported.
Irish et al. (2013) [37]
USA
N ¼ 128
63% male
36.45 y
92% white
Change in self-reported
sleep quality (PSQI).
Self-report physical
symptoms.
Immune marker e
natural killer cell
number and
cytotoxicity (n ¼ 51).
12 mo Two time points.
Predicting variable
assessed at baseline
and follow-up. Pain-
related health outcome
assessed only at follow-
up.
None stated. Deterioration of sleep
quality not signiﬁcantly
correlated with pain-
related health outcomes at
follow-up.
Improvement in sleep
quality not signiﬁcantly
correlated with pain-
related health
outcomes at follow-up.
Janson et al. (2001) [54]
Sweden
N ¼ 2602
100% male
Not stated
range 30e69 y
not stated
Change in self-reported
insomnia symptoms
(difﬁculty falling asleep and
difﬁculty maintaining
sleep).
Diagnosis of a medical
disorder, including
joint or low back
disorders by physician.
10 y Predicting variable and
pain-related health
outcome assessed at
two time points
(baseline and follow-
up).
Age, BMI smoking, physical
inactivity, alcohol
dependence, and medical
disorders.
Increase in insomnia
symptoms associated with
newly reported medical
disorder at follow-up.
None reported.
Komada et al.
(2012) [49]
Japan
N ¼ 1577
43% male
58.6 y
not stated
Change in self-reported
sleep quality (Japanese
version of PSQI e cut-off
score of 5.5 indicating
insomnia).
SF36 e PCS 2 y Predicting variable and
pain-related health
outcome assessed at
two time points
(baseline and follow-
up).
Age, gender, disease status,
alcohol consumption,
smoking habits, living
status, sleep medication
use, CES-D, MCS, PCS, and
PSQI scores at baseline.
New incidence of insomnia
symptom associated with a
decline in PCS scores at
follow-up.
Remission of insomnia
symptoms not
signiﬁcantly associated
with increase in PCS
scores at follow-up.
Parthasarathy
et al. (2015) [56]
USA
N ¼ 1409
45% male
47 y
not stated
Change in self-reported
insomnia symptoms
derived from ICSD insomnia
diagnosis criteria.
Immune marker e CRP
levels assessed in 722
participants.
6 y Two time points.
Predicting variable
assessed at baseline
and follow-up. Pain-
related health outcome
assessed only at 6-
y follow-up.
Age, gender, BMI, smoking,
physical activity, use of
alcohol and medications to
get to sleep, marital status,
habitual snoring, diabetes
mellitus and hypertension.
Persistence of insomnia
symptoms associated with
an increase in and higher
CRP levels at follow-up
compared to those with
intermittent or no
insomnia.
None reported.
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Quan et al. (2005) [55]
USA
N ¼ 4667
40.9% male
72.3 y
not stated
Change in self-reported
insomnia symptoms
(trouble falling asleep,
frequent awakenings and
excessive daytime
sleepiness).
Diagnosis of arthritis by
physician.
1e4 y
(mean 3.55)
Predicting variable and
pain-related health
outcome assessed at
two time points
(baseline and follow-
up).
Age, gender, race, time
interval between baseline
and follow-up
examinations.
New incidence of insomnia
symptoms associated with
report of arthritis in
women.
None reported.
Rueggeberg et al.
(2012) [38]
Canada
N ¼ 157
48.40% male
71.71 y
not stated
Change in self-reported
sleep quantity using items
from PSQI.
Immune marker e
diurnal cortisol
secretion.
4 y Predicting variable and
pain-related health
outcome assessed at
three time points
(baseline, 2 y and 4 y).
Age, gender, partnership
status, education, chronic
illness, cortisol-related
medication usage, BMI and
smoking.
Decrease in sleep quantity
associated with signiﬁcant
increases in cortisol
secretion level at follow-up.
Increase in sleep
quantity not
signiﬁcantly associated
with changes in cortisol
level at follow-up.
Ropponen et al.
(2013) [58]
Finland
N ¼ 18,979
47% male
45 y
not stated
Change in self-reported
sleep quality and sleep
quantity.
Diagnosis of back pain
by physician and
included in national
register database on
disability pension due
to low back pain
diagnosis.
23 y Two time points.
Predicting variable
assessed at baseline
and follow-up. Pain-
related health outcome
assessed only at follow-
up.
Age, education,
socioeconomic status,
marital status, BMI, physical
activity, musculoskeletal
pain locations, smoking,
alcohol, life satisfaction, use
of hypnotic agents, diurnal
type, and type of work.
Deterioration and
persistent of poor sleep
quality associated with
higher risk of low back pain
diagnosis at follow-up
(HR ¼ 1.84 95% CI 1.01
e3.37). No association with
decrease in sleep quantity.
Improvement in sleep
quantity and quality
not associated with risk
of low back pain
diagnosis at follow-up.
Shakhar et al.
(2007) [39]
USA
N ¼ 45
0% male
39.7 y
47% white
40% black
Change in self-reported
sleep quantity.
Immune marker e
NKCA levels.
1 mo Two time points.
Predicting variable and
pain-related health
outcome assessed at
both baseline and
follow-up.
POMS Depression and
Tension subscales scores.
Decrease in sleep quantity
not associated with NKCA
levels at follow-up.
Increase in sleep
quantity was
signiﬁcantly related to
an increase in NKCA
levels at follow-up.
Silva et al. (2009) [40]
USA
N ¼ 3078
45% male
67.3 y
75% white
Change in self-reported
insomnia symptoms
(difﬁculty initiating and
maintaining sleep, daytime
sleepiness).
SF36 e PCS. 5 y Predicting variable and
pain-related health
outcome assessed at
two time points
(baseline and follow-
up).
Age, gender, BMI, smoking,
sleeping pill use, PSG total
sleep time, baseline
coronary heart disease and
respiratory disease.
Deterioration of insomnia
symptoms was not
associated with PCS scores.
Increase in daytime
sleepiness was associated
with decline in PCS scores
at follow-up.
Improvement of
insomnia symptoms
not signiﬁcantly
associated with PCS
scores at follow-up.
Smagula et al.
(2016) [57]
Singapore
N ¼ 8265
41.05% male
64.59 y
98.6% asian
Change in self-reported
sleep quantity.
Diagnosis of arthritis by
physician and diagnosis
of hip fracture recorded
on hospital database.
12.7 y Predicting variable and
pain-related health
outcome assessed at
two time points
(baseline and follow-
up).
Age, gender, baseline sleep
duration.
No association between
change in sleep and
arthritis. Increase in sleep
quantity from 6 to 8 to >8 h
was linked with greater risk
of hip fracture at follow-up
(OR ¼ 1.52 95% CI 1.16
e2.00).
None reported.
Suh et al. (2014) [41]
Korea
N ¼ 1247
40.1% male
54.3 y
not stated
Change in self-reported
insomnia symptoms
(difﬁculty initiating and
maintaining sleep, early
morning awakenings and
unrefreshed in the
morning).
SF36 e PCS. 2 y Predicting variable and
pain-related health
outcome assessed at
three time points
spread over 2 y.
Age, gender, marital status,
employment, smoking,
alcohol, hypertension,
diabetes, depression, PSQI
and BMI score.
Deterioration and
persistence of insomnia
symptoms associated with
signiﬁcantly lower PCS
scores at follow-up.
None reported.
Zhang et al. (2012) [42]
Hong Kong
N ¼ 2291
50% male
46.3 y
not stated
Change in self-reported
insomnia symptoms (non-
restorative sleep).
Subjective physical
health status.
Diagnosis of arthritis
and other chronic pain
condition by physician.
5 y Predicting variable and
pain-related health
outcome assessed at
two time points
(baseline and follow-
up).
Age, gender, education,
family income, medication,
and comorbid sleep
problems (insomnia
subtypes, habitual snoring,
short sleep duration).
New incidence of insomnia
symptoms signiﬁcantly
associated with higher risk
of reporting a chronic pain
condition at follow-up
(OR ¼ 2.47 95% CI 1.30
e4.69)
Remission of insomnia
symptoms associated
with a relatively
lowered risk of
developing a chronic
pain condition at
follow-up (OR ¼ 1.23,
95% CI 0.57e2.59).
BMI: bodymass index, CES-D: center for epidemiological studies depression scale, CI: conﬁdence interval, CRP: creatinine reactive protein, HR: hazard ratio, ICSD: international classiﬁcation of sleep disorders, IL-6: interleukin-6,
MCS: mental component summary, NKCA: natural killer cell activities, OR: odds ratio, PCS: physical component summary, POMS: proﬁle of mood states, PSG: polysomnography, PSQI: Pittsburgh sleep quality index.
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StaƟsƟcal methods
Design-specific issues
Measurement methods
SelecƟon of parƟcipants
Number of studies
High risk Moderate risk Low risk
Figure Key: High risk Moderate risk Low risk 
SelecƟon and 
assessment of 
parƟcipants
Minimal descripƟon of 
parƟcipants and inclusion 
characterisƟcs. 
Sample size n < 100 with 
no jusƟficaƟon given and 
two follow-up 
assessments.
Ref: 53, 39
Some but insuﬃcient 
descripƟon of parƟcipants 
and inclusion 
characterisƟcs.
Sample size n = 100 – 1000 
and no jusƟficaƟon given 
but at least two follow-up 
assessments. 
Ref: 54,49,38,42,37,56,57
Clear detailed descripƟon 
of parƟcipants and 
inclusion characterisƟcs. 
Sample size n > 1000 or 
jusƟficaƟon of sample 
size, and more than two 
follow-up assessments
Ref: 55,40,52,36,58,51,41
Measurement 
methods 
Uses only non-validated 
subjecƟve measure of 
exposure or outcome.
Ref: 53,54,55,42
Uses only validated 
subjecƟve measure of 
exposure or outcome.
Ref: 39,49,38,52,36,37,58,
51,41,56,57
Uses a standard objecƟve 
and a validated 
subjecƟve measure of 
exposure and outcome.
Ref: 40
Design – specific 
issues 
AƩriƟon rate > 80%. 
Minimal descripƟon of 
aƩriƟon levels and 
comparison of non-
responders with 
parƟcipaƟng individuals.
Very liƩle/no 
confounding variables 
stated and controlled for. 
Ref: 53,57
AƩriƟon rate 60 – 80%. 
Insuﬃcient descripƟon of 
aƩriƟon levels and 
comparison of non-
responders with 
parƟcipaƟng individuals.
Limited range of 
confounding variables 
stated and controlled for. 
Ref: 55,39,40,38,42,36, 
37,58,51,41,56
AƩriƟon rate < 60%. 
Clear descripƟon and 
comparison of non-
responders with 
parƟcipaƟng individuals.
Describes and controls 
for a range of relevant 
confounding variables.
Ref: 54,49,52
StaƟsƟcal 
methods
Poorly described 
staƟsƟcal analysis.
Lack of appropriate 
significance tesƟng and 
minimal jusƟficaƟon for 
lack of further sensiƟvity 
analysis. 
Ref: N/A
StaƟsƟcal analysis methods 
not suﬃciently described. 
Insuﬃcient details to jusƟfy 
lack of further sensiƟvity 
analysis. 
Ref: 54,39,37,41
Well-described and 
appropriate staƟsƟcal 
analysis.
Reports adjusted 
esƟmates, missing data, 
subgroups and other 
sensiƟvity analysis. 
Ref: 53,55,40,49,38,42
52,36,58,51,56,57
Fig. 3. Risk of bias checklist and rating adapted from STROBE guidelines for reporting observational epidemiological studies and modiﬁed AHRQ quality assessment criteria for
observational studies. AHRQ: agency for healthcare research and quality, STROBE: strengthening the reporting of observational studies in epidemiology.
E.F. Afolalu et al. / Sleep Medicine Reviews xxx (2017) 1e168was only used to index overnight respiratory disturbance and no
other objective sleep parameters were reported.
Measures of pain-related health outcomes
Seven studies [42,51,53e55,57,58] focused on looking at change
in sleep and risk of developing a pain-related health condition
(namely; arthritis, back pain, general chronic pain, hip fractures) byPlease cite this article in press as: Afolalu EF, et al., Effects of sleep cha
systematic review of longitudinal studies with exploratory meta-an
j.smrv.2017.08.001means of self-report or using information from physician medical
interviews, medical records, and linked national databases. Four
studies [36,38,39,56] assessed changes in sleep in relation to
physiological health status. This included assessments of inﬂam-
matory and immune system biomarkers. There was no restriction
placed on the diversity of biomarkers, as long as they were immune
or inﬂammatory biomarkers with established connection to pain
conditions [59]. Three studies [40,41,49] assessed the effect ofnges on pain-related health outcomes in the general population: A
alysis, Sleep Medicine Reviews (2017), http://dx.doi.org/10.1016/
E.F. Afolalu et al. / Sleep Medicine Reviews xxx (2017) 1e16 9changes in sleep on self-reported pain-related health status, mostly
using the PCS and bodily pain scores derived from the SF-36. One
study [52] used a general health assessment questionnaire to
determine pain presence and pain interference. Only one study [37]
assessed changes in both self-reported physical pain symptoms and
immune biomarkers.
Risk of bias assessment results
The results of the risk of bias assessment are graphically pre-
sented in Fig. 3. Most of the reviewed studies were “low/medium
risk” except for one [53], which was categorised as “high risk” in
three out of the four risk categories. The main issues affecting the
quality of the included studies were a heavy reliance on self-report
and a lack of objective sleep/pain-related health outcomemeasures
(i.e., polysomnography-determined sleep and quantitative sensory
testing). In addition, some studies provided insufﬁcient details on
attrition, resulting in a lack of comparison with non-responding
participants, which could affect the generalisability of association
between variables and bias the interpretation of the results. Finally,
other methodological issues included studies with small sample
sizes (e.g., less than 50 in one study) and short follow-up period
(i.e., 1 mo) for a longitudinal design. Small sample size in itself may
not be an issue when combined with greater numbers of follow-up
assessments as this would increase statistical power. However,
statistical power to detect signiﬁcant association will be limited in
the case of both a small sample size and limited follow-up
assessments.
Association of change in sleep with the risk of developing a pain
condition
Increase in insomnia symptoms
The reviewed studies conveyed the relationship between a
negative change in insomnia symptoms and risk of developing a
pain condition in those with no pain condition at baseline. Foley
et al. [53] reported that newly developed insomnia symptoms over
a three-year period doubled the risk of the presence of self-
reported hip fracture problems at follow-up (OR ¼ 2.08 95% CI
1.18, 3.65). Zhang et al. [42] also reported that incidence of insomnia
symptoms and non-restorative sleep was associated with over a
two-fold increase in risk of reporting a chronic pain disorder at ﬁve-
year follow-up (OR¼ 2.47 95% CI 1.30e4.69). Agmon and Armon [51]
showed that increase in insomnia symptoms was associated with a
40% increased risk of new back pain diagnosis over a period of over
3 y (OR ¼ 1.40 94% CI 1.10e1.71). With a much longer follow-up
period of 23 y, Ropponen et al. [58] reported an association of
persistent poor sleep (HR ¼ 1.84 95% CI 1.01e3.37) with an 84%
increased risk of being included on the national register for
disability pension due to low back pain diagnosis at follow-up.
However, reduction in sleep quality (HR ¼ 1.17, 95% CI 0.77e1.77)
was not signiﬁcantly associated with an increased risk. Janson et al.
[54] also found that an increase in insomnia symptoms over a ten-
year period was associated with newly reportedmedical conditions
including joint and low back pain disorder at follow-up, although
the risk ratios were not speciﬁed in the report. In contrast to the
other studies, Quan et al. [55] did not ﬁnd a link between the
development of insomnia symptoms over a four-year period and
the presence of pain conditions at follow-up.
Decrease in insomnia symptoms
Notably, only Zhang et al. [42] reported the effect of a positive
change in insomnia symptoms. They reported an association of
remission of insomnia symptoms with a 23% lowered risk ofPlease cite this article in press as: Afolalu EF, et al., Effects of sleep cha
systematic review of longitudinal studies with exploratory meta-an
j.smrv.2017.08.001developing a chronic pain condition at follow-up, but this associ-
ation was not signiﬁcant (OR ¼ 1.23, 95% CI 0.57e2.59).
Increase in sleep quantity
Ropponen et al. [58] did not ﬁnd an association between
increased sleep quantity and risk of low back pain diagnosis over a
23-y follow-up period. Smagula et al. [57] similarly did not ﬁnd a
link between an increase in sleep quantity and developing arthritis
at ten-year follow-up. However, these authors did report that an
increase in nightly sleep quantity to >8h was associated with a 52%
greater risk of hip fracture problems as registered on a national
hospital database (OR ¼ 1.52 95% CI 1.16e2.00). The causal order of
the relationship was unclear; the authors suggested that recent hip
fractures and consequent low physical activity might be key de-
terminants of the lengthened sleep duration.
Summary e change in sleep and risk of developing a pain condition
In the studies reviewed, reporting a negative change in
insomnia symptoms was associated with a greater risk of devel-
oping and reporting a pain-related medical condition. On the other
hand, a remission or a positive change in insomnia symptoms did
not necessarily neutralise or fully avert the risk of developing
chronic pain. Moreover, an increase in sleep quantity might not be
associated with a positive pain-related health outcome.
Association of change in sleep with inﬂammatory or immune
biomarkers
Increase in sleep quantity and natural killer cells activities (NKCA)
Shakhar et al. and Irish et al. [37,39] looked at the association
between changes in sleep quantity and natural killer cells activities
(NKCA). Natural killer cells play a physiologically protective role in
activating immune responses to contain and clear viral infections.
Low levels are linked to certain pain conditions such as ﬁbromy-
algia, and possibly contributing to exaggerated pain response in
some individuals with chronic pain [59,60]. Shakhar et al. [39] using
a small sample (n¼ 45) with a short (1 mo) follow-up found that an
increase in sleep quantity was associated with an increase in NKCA
levels. On the other hand, Irish et al. [37] did not ﬁnd a relationship
between either an increase or decrease in sleep quantity and
quality over 1-y with changes in natural killer cell levels. The
analysis was carried out in a small subset (n ¼ 51) of their sample
and the standard deviation for mean NK cell number was quite
large (Mean ¼ 285.21, SD ¼ 204.53).
Decrease in sleep quantity and cortisol levels
Cortisol is the body's primary stress hormone needed to activate
the physiological ‘ﬂight or ﬁght’ response; however, high cortisol
levels interfere with immune functions and are a risk factor for
many illnesses [61,62]. Chronic pain states have been linked to
sustained stress response and consequently higher cortisol levels
[63]. Rueggeberg et al. [38] found that a decrease in sleep quantity
(by one standard deviation) over the ﬁrst two years of their study
was associated with an increase in diurnal cortisol secretion over
the total four-year follow-up period. By contrast, an increase in
sleep quantity was not signiﬁcantly associated with cortisol levels.
Decrease in sleep quantity and interleukin-6 (IL-6) and C-reactive
protein (CRP) levels
IL-6 and CRP are markers of systemic inﬂammation, activated to
combat infections [64]. They also possess a pain facilitatory effect
and can alter pain modulation and pain processing [32,65,66].
Persistent elevated presence of these markers has been observed in
several chronic illnesses and implicated in the generation, main-
tenance, and severity of chronic pain conditions [59,67]. Ferrie et al.nges on pain-related health outcomes in the general population: A
alysis, Sleep Medicine Reviews (2017), http://dx.doi.org/10.1016/
E.F. Afolalu et al. / Sleep Medicine Reviews xxx (2017) 1e1610[36], analysing data from the UK Whitehall study, did not ﬁnd an
association between increases in sleep quantity and changes in
levels of IL-6 and CRP. However, they revealed that a ﬁve-year
decrease in sleep quantity was associated with higher levels of
inﬂammatory markers. In the fully-adjusted analysis controlling for
age, sex, occupation, blood pressure, BMI, cholesterol level and
presence of diabetes, each 1-h decrease in sleep quantity was
associated with a 2.7% higher level of IL-6. The reduction in sleep
quantity was also associatedwith a 4.2% higher level of CRP, but this
association was not statistically signiﬁcant.
Summary e change in sleep and inﬂammatory or immune
biomarkers
It appeared that a reduction in sleep quantity is temporally
linked to elevated levels of inﬂammatory and immunological
markers. However, a reverse association was not noted for an in-
crease in sleep quantity. Only one study examined the effect of
changes in insomnia symptoms and sleep quality on inﬂammatory
and immunological markers indicative of pain. Parthasarathy et al.
[56] found that CRP levels were higher and increased at a greater
rate in those with persistent insomnia compared with those with
intermittent or no insomnia. It is important to note that the bio-
markers reviewed were not pain-speciﬁc. We cannot rule out other
disease processes involving inﬂammation that might have affected
the relationship of sleep changes with deterioration in health
status.
Association of change in sleep with pain-related health status
Three of the reviewed studies [40,41,49] assessed perceived
physical health status using the PCS from the SF-36. PCS is a sum-
mary of the SF-36 subscales that assess physical functioning,
physical role functioning, bodily pain and general health [48].
Lower scores on the PCS and the bodily pain subscale indicate
greater physical health limitations and pain-related interference
and disability. All three studies reviewed reported the PCS scores,
but only the Silva et al. [40] study provided the subcomponent
bodily pain score separately.
Increase in insomnia symptoms
All three studies revealed an association of lowered PCS scores
over time with an increase in or maintenance of insomnia symp-
toms. Silva et al. [40] found that those who developed insomnia
symptoms or whose insomnia symptoms persisted over a ﬁve-
year follow-up period reported a decline in PCS scores and lower
PCS scores at follow-up, compared with persistent good sleepers
with no change in insomnia symptoms. Komada et al. [49] used
PSQI scores to assess those with newly developed insomnia
symptoms over a two-year follow-up period. These individuals
who reported increased insomnia symptoms over time reported a
decline in PCS scores from baseline to follow-up and worse PCS
scores at follow-up compared with persistent good sleepers. Suh
et al. [41] also reported a similar decrease in PCS score over a 2-
y follow-up period for those with worsening and persistent
insomnia symptoms.
Two studies used other forms of pain health assessment such as
self-reported pain symptoms. Irish et al. [37] did not ﬁnd a one-year
increase or decrease in PSQI to be related to physical pain symp-
toms. In their sample of rescue workers who performed rescue and
clean-up operations at the site of a major aeroplane crash, the
ﬁndings might have been affected by life stressors and other
symptoms of psychological distress following the crash. However,
over 80% of the sample reported ‘good’ or ‘excellent’ physical health
and had stable PSQI scores over the year. Campbell et al. [52] on the
other hand found that new onset of sleep problems and insomniaPlease cite this article in press as: Afolalu EF, et al., Effects of sleep cha
systematic review of longitudinal studies with exploratory meta-an
j.smrv.2017.08.001symptoms in a chronic pain sample over three years signiﬁcantly
increased the risk of depression (relative risk 3.47) at six-year
follow-up. Importantly, this risk was mediated by increased pain
interference measured at three-year follow-up and the ﬁndings
revealed a signiﬁcant association between increased insomnia
symptoms and increased pain interference.
Summary e change in sleep and pain-related health status
Compared to no change in good sleep, an increase in insomnia
symptoms was both a predictor and an indicator of worse pain
outcomes and physical functioning status over time.
Sleep change trajectories and PCS scores
To further explore the observed trend of changes in sleep and
physical functioning, we quantitatively and visually compared
changes (Fig. 4) in PCS from baseline to follow-up by sleep change
trajectories. Namely, the four trajectories are i) persistent good
sleepers (no sleep disturbance at baseline and follow-up), ii) new
incident poor sleepers (developed sleep disturbance from baseline
to follow-up), iii) remitted poor sleeper (sleep disturbance resolved
from baseline to follow-up), and iv) persistent poor sleepers (sleep
disturbance at baseline and follow-up).
Across the three studies with this kind of data [40,41,49],
persistent good sleepers fared the best and reported the highest
PCS scores at both baseline and follow-up compared with the other
trajectories. They also showed the greatest stability in PCS scores
across both time points. New incident poor sleepers showed a
decline in PCS scores. Whilst the PCS scores for remitted poor
sleepers also showed ﬂuctuations, the effect was not consistent
across studies and the direction of the effect was unclear. Persistent
poor sleepers fared the worst; they presented with the lowest PCS
scores at both baseline and follow-up.
We could not extract subcomponent scores for bodily pain for all
three studies, but using the data available from Silva et al. [40], we
were able to compare the different sleep change trajectories using
the bodily pain subscale of the PCS for this particular study. We
noted that remitted poor sleepers had the highest bodily pain score
at baseline and this worsened at follow-up. However, the other
patterns observed for the bodily pain subscale were similar to
overall PCS scores; persistent good sleepers fared the best whereas
new incident poor sleepers showed an increase in pain scores over
time.
Exploratory meta-analysis
We carried out three exploratory meta-analyses to compare PCS
score at follow-up to examine how different trajectories of sleep
changes affected physical health. We used available data from the
three studies [40,41,49] using PCS as an outcomemeasure. The total
number of participants across the three studies was 5902 (female:
57.1%, mean age: 60 y) and the follow-up periods were 5 y and 2 y.
We used an analytic approach that allowed us to compare the PCS
scores at follow-up between persistence of poor sleep and good
sleep, and then examine the separate effect of sleep deterioration
and sleep improvement on PCS scores. Statistics of these analyses
are summarised with forest plots in Fig. 5aec.
Meta-analysis 1: Persistence of poor sleep and PCS scores
In comparing persistent poor sleep with persistent good sleep
(Fig. 5a), persistent poor sleep was signiﬁcantly associated with
lower PCS scores at follow-up. This analysis showed signiﬁcant
heterogeneity (I2 ¼ 67%). Sensitivity analysis identiﬁed Komada
et al. [49] as the potential source, possibly due to the use of a Jap-
anese version of the PSQI compared to individual questions fornges on pain-related health outcomes in the general population: A
alysis, Sleep Medicine Reviews (2017), http://dx.doi.org/10.1016/
Fig. 4. Comparison of PCS and SF-36 bodily pain scores from baseline to follow-up for different sleep change trajectories (Lower scores on the PCS and bodily pain subsection
indicates greater physical health limitations and pain related interference and disability).
E.F. Afolalu et al. / Sleep Medicine Reviews xxx (2017) 1e16 11assessing insomnia symptoms as used in the other studies. Omit-
ting this study reduced I2 from 67% to 39% and decreased the effect
from 0.47 to 0.41 (95% CI 0.54, 0.25) Z ¼ 6.23, p < 0.00001.
This standardised mean difference indicates a medium effect size
and that approximately 66% of those with persistent poor sleep had
worse PCS scores at follow-up than those with persistent good
sleep.
Meta-analysis 2: Sleep deterioration and PCS scores
New poor sleepers were compared with persistent good
sleepers to assess the effect of sleep deterioration over time
(Fig. 5b). Developing insomnia symptoms was associated with
signiﬁcantly lower PCS scores at follow-up compared with persis-
tent good sleep. There was no signiﬁcant heterogeneity across the
studies. A standardised mean difference of 0.33 (95%
CI 0.41, 0.24) Z ¼ 7.68, p < 0.00001 is a medium effect size
indicating that approximately 62% of those who developed sleep
problems from baseline to follow-up had worse PCS scored at
follow-up than those with persistent good sleep.
Meta-analysis 3: Sleep improvement and PCS scores
Finally, remitted poor sleepers were compared with persistent
poor sleepers to assess the effect of sleep improvement over time
(Fig. 5c). Remission of insomnia symptoms was signiﬁcantly asso-
ciated with higher PCS scores at follow-up compared with persis-
tent poor sleepers whose sleep problems showed no improvement.
However, the analysis did show heterogeneity across the two
studies (I2 ¼ 60%). Given that only two studies were included in the
analysis, we were unable to conduct a sensitivity analysis to iden-
tify the source of heterogeneity. The standardised mean difference
effect of 0.23 (95% CI 0.05, 0.41) Z ¼ 2.51, p < 0.01, which if het-
erogeneity was not an issue, suggests that approximately 58% of
those with improvement in sleep from baseline to follow-up had
better PCS scores at follow-up than those with persistent sleep
problems.Please cite this article in press as: Afolalu EF, et al., Effects of sleep cha
systematic review of longitudinal studies with exploratory meta-an
j.smrv.2017.08.001Summary e exploratory meta-analyses
Findings from the exploratory meta-analyses suggest that inci-
dence and persistence of sleep problems may contribute to worse
physical health over time. Remission of sleep disturbances was
associated with better outcome but the effect was weak. PCS scores
usually have high test-retest reliability in the general population,
yet, we see a drop in PCS scores in those with persistent sleep
problems and those who newly developed sleep problems. Such
drop in PCS scores could be interpreted as signifying “some more”
physical limitation among these individuals [48]. Moreover, the PCS
scores of these individuals at follow-up were comparable to levels
of PCS scores observed in population groups with minor medical
conditions or serious physical illnesses [48,68]. Together, these
ﬁndings suggest a detrimental effect of deterioration in sleep
quality andmaintenance of sleep problems in contrast to persistent
good sleep.
Discussion
Summary of ﬁndings
Findings from this systematic review andmeta-analysis indicate
that sleep deterioration has a negative effect on pain-related health
outcomes. There was, however, insufﬁcient evidence to suggest a
clear positive effect of sleep improvement on pain. Overall, the
ﬁndings extend previous evidence highlighting poor sleep at
baseline as a risk factor for developing a future pain condition
[24,25,69]. The review further consolidates evidence that changes
in sleep are prospectively associated with the experience of pain,
adding weight to the argument for a causal association.
Disentangling the effect of different sleep parameters
Sleep is a multidimensional construct and research has sug-
gested that sleep quality and other aspects of sleep behaviours (e.g.,nges on pain-related health outcomes in the general population: A
alysis, Sleep Medicine Reviews (2017), http://dx.doi.org/10.1016/
Fig. 5. Forest plots summarising the effects of changes in sleep on PCS scores at follow-up. Lower PCS scores represent poorer physical functioning. a) Compares individuals who
were ‘persistent poor sleepers’ with those who were ‘persistent good sleepers’ over time. b) Compares individuals who developed sleep disturbances over time (‘new poor sleepers’)
with those who were ‘persistent good sleepers’ (i.e. evaluating the effect of negative sleep deterioration). c) Compares individuals whose sleep disturbances remitted over time
(‘remitted poor sleepers’) with those who were ‘persistent poor sleepers’ (i.e. evaluating the effect of positive sleep improvement).
E.F. Afolalu et al. / Sleep Medicine Reviews xxx (2017) 1e1612use of sleep medications) may be more strongly associated with
future health and well-being and should be considered alongside
sleep quantity [70,71]. Notably, it emerged from this review that
changes in sleep quality but not sleep quantity were associated
with the risk of developing a pain condition and worse self-
reported health outcomes. Whereas, changes in sleep quantity
were mostly reported to be contributing to altered levels of pain-
related biomarkers. These differing patterns of association reﬂect
potential speciﬁcity in the roles of sleep quality and quantity on
pain.
That said, we note that there were considerable variations
across studies in the way changes in insomnia symptoms, sleep
quality and quantity were measured. Some studies reported
changes in insomnia symptoms such as difﬁculty in initiating and
maintaining sleep, some assessed only reports of non-restorative
sleep, and others used questionnaires to assess sleep quality. For
sleep quantity, some used predetermined sleep duration cate-
gories, e.g., short (<7 h), average (7e8 h), and long (>8 h), whilst
others gathered single-item responses on average nightly sleep
duration. In addition, these measures also vary in assessment of
severity and chronicity of sleep problems, with studies assessingPlease cite this article in press as: Afolalu EF, et al., Effects of sleep cha
systematic review of longitudinal studies with exploratory meta-an
j.smrv.2017.08.001different sleep problems (e.g., mild vs. severe symptoms) across
different time frames (e.g., currently, past month, past year, or in a
lifetime). This further limits generalisation and meaningful
comparisons.
Distinctions should also be made between insomnia symptoms
and general dissatisfaction with sleep quality and quantity, as
changes in insomnia symptoms and other sleep disturbance pa-
rameters may have differential effects on different health outcomes
[11]. Cross-sectional studies have provided some evidence to sup-
port this; Yokohama et al. [72] compared three sub-symptoms of
insomnia e difﬁculty initiating sleep, early morning awakenings
and difﬁculty maintaining sleep, and they found that difﬁculty
initiating sleep was more strongly associated with depression than
the other insomnia symptoms. Consequently, future studies
exploring the association of sleep changes should consider not only
assessing different parameters of sleep disturbances but also using
standardised measures. Similar recommendations for assessing
core outcome measures have been made for trials of chronic pain
treatment efﬁcacy and effectiveness. The initiative on methods,
measurement, and pain assessment in clinical trials (IMMPACT)
proposed and encouraged the use of key standardised measures fornges on pain-related health outcomes in the general population: A
alysis, Sleep Medicine Reviews (2017), http://dx.doi.org/10.1016/
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tioning, emotional functioning and improvement and satisfaction
with treatment [73]. Whilst it is appreciated that aspects of such
proposal may be more applicable to clinical trials than longitudinal
studies, the IMMPACT recommendations can be useful as an illus-
trative guideline on how core sleep outcomes could be measured,
deﬁned, and reported for improving comparability and interpret-
ability across studies.
Mechanisms underlying the interaction between sleep and pain-
related biomarkers
The current review shows that a negative change in sleep
quantity may be a key predictor of elevated pro-inﬂammatory
markers and deterioration of pain-related physical health over
time. There is also some evidence suggesting that a negative change
in insomnia symptoms is associated with raised inﬂammatory
levels. These ﬁndings are consistent with longitudinal studies that
have reported baseline sleep quality as a predictor for pathogenic
levels of inﬂammatory markers at follow-up [74,75]. That said, the
observed effect on these biomarkers may not be pain-speciﬁc but
reﬂecting a decline in physiological health status in general. Future
development of a more comprehensive biopsychosocial model
linking sleep quality, pain, and inﬂammation would enable more
rigorous examination of the underpinning physiological mecha-
nisms [76]. It is thought that the effects of sleep problems on pain
responses are mediated by impaired immunity, elevated inﬂam-
matory responses and raised cytokines levels such as those
assessed by studies considered in this review, namely IL-6, CRP, and
cortisol [30,31]. However, their meditational roles are yet to be
veriﬁed in the general population whereby sleep disruptions and
pain symptoms are assessed in a more naturalist way with
ecological validity.
Clarifying the effect of sleep improvement on pain outcomes
Findings from this review suggest that deterioration in sleep and
persistent poor sleep are key risk factors of poor health. However,
the ﬁndings do not provide sufﬁcient evidence that an improve-
ment in sleep quality or an increase in sleep quantity has a pro-
tective function of mitigating disease risk, as many clinicians and
researchers would assume. The meta-analysis revealed that the
development of sleep problems over time has a negative effect on
self-reported physical health [48,68]. The meta-analysis also
showed that remission of sleep problems over time was associated
with higher PCS scores at follow-up, but the effect size was small
and was only signiﬁcant when compared with those who reported
persistent poor sleep. However, the amount of evidence available
for the current review was limited due to the small number of
studies examining positive sleep changes over time outside of the
context of a clinical trial.
There is some evidence emerging to suggest that naturally
occurring good sleep is a potential predictor of chronic pain
remission in the general population. Aili et al. [77] reported in their
prospective analysis that out of 883 participants from the general
population, for the 53 individuals who reported multi-site pain at
baseline but not at follow-up, a lack of or minimal report of sleep
disturbance at baseline was a signiﬁcant predictor of the ‘resolu-
tion’ of their multi-site pain (adjusted OR 3.96 95% CI 1.69e9.31),
after controlling for age, gender, smoking, BMI, physical occupa-
tional risks, and psychosocial activities. However, the small size of
the group limits the statistical power, risk estimation, and gen-
eralisability of these ﬁndings. Davies et al. [78] similarly showed
that self-reported restorative sleep at baseline was a predictivePlease cite this article in press as: Afolalu EF, et al., Effects of sleep cha
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j.smrv.2017.08.001factor for the ‘resolution’ of chronic widespread pain (adjusted OR
2.0 95% CI 1.02e3.8) in 300 of the 679 participants presenting with
pain at baseline but not at follow-up. However, the participants in
this study who reported resolvedwidespread pain at follow-up still
reported some regional pain. As such, the impact of restorative
sleep on pain experience may have been overstated. What these
studies are not able to say is whether resolution in pain are pre-
ceded by positive changes in sleep and to what extent improve-
ment in pain is sustained. The current review has highlighted that
there is room for further longitudinal studies with longer follow-
up, to strengthen the evidence for the impact of sleep improve-
ment on long-term pain outcomes.
Methodological considerations and recommendations
Although the included studies were mostly of low and medium
risk of bias, there were some recurrent methodological issues that
could affect the rigour and generalisability of the ﬁndings and
conclusions drawn. Based on the ﬁndings of the risk of bias
assessment in the current review, future studies could improve
methodological rigour by clarifying the rate of participation and
attrition and by ensuring sufﬁcient statistical power for detecting
signiﬁcant (and meaningful) results over a sufﬁciently long follow-
up period. Two further speciﬁc recommendations are offered
below:
I. Improving research designs to substantiate the impact of
changes in sleep on pain outcomes
One of the main methodological drawbacks noted in the
included studies was a reliance on self-report and a lack of objective
sleep and quantitative pain outcome measures. Objective sleep
assessments beyond self-report are less vulnerable to reporting
biases. It is important for future prospective studies to strive to
include assessment of both self-reported and objective changes in
sleep using polysomnography or actigraphy. This can then be used
in combination with quantitative sensory testing that assesses
normal and abnormal psychophysical pain responses and physio-
logical pain sensitivity. Whilst these methods would increase
research costs, they are often utilised in experimental studies and
could have an equally important role to play in sleep epidemiology
research that combines experimental laboratory studies with lon-
gitudinal follow-up assessments. This would provide clarity in our
understanding of the physiological factors underlying sleep and
pain disturbances.
In addition, the evidence from the meta-analysis was also
restricted to a broad evaluation of general physical health and well-
being scores derived from the SF-36. For example, only one of the
included studies [40] provided data speciﬁcally on PCS bodily pain
subcomponent scores over time, whereas none of the other studies
with PCS scores as an outcome measure allowed for this level of
detail for comparison. Future studies should also consider using
other pain measures to better demonstrate the long-term temporal
relationship between sleep and pain intensity. Additional repeated
ratings of pain [79] can mark the trajectory of pain intensity over
time and clarify the inﬂuence of pain intensity, rather than pain
interference, on health outcomes.
II. Improving longitudinal assessments of sleep and pain
Most of the reviewed studies have just two assessment points.
Two observations are the bare minimum needed to provide infor-
mation about change over time, but this information is usually
insufﬁcient for a thorough understanding of the processesnges on pain-related health outcomes in the general population: A
alysis, Sleep Medicine Reviews (2017), http://dx.doi.org/10.1016/
Practice points
1) This systematic review of longitudinal studies illuminates
the prospective associations between i) changes in sleep
and subsequent risk of developingpain conditions, and ii)
changes in sleep and subsequent self-report of pain-
related health status. There is also some preliminary
evidence for iii) changes in sleep and subsequent
inflammatory or immune function biomarkers.
 A general decline in sleep quality and sleep quantity
was associated with a greater risk of developing a pain
condition, small elevations of inflammatory markers,
and a decline in self-reported physical health status.
2) An exploratory meta-analysis was carried out to quanti-
tatively estimate the magnitude of the effect of sleep
changes on self-reported pain-related physical health
status.
 New incidence and persistence of sleep problems may
contribute toworse perceived physical functioning over
time (medium effect size). Compared with consistently
good sleepers, those with new and persistent sleep
problems reported ‘somemore’ physical limitation than
usual as indicated by a decrease in PCS scores.
 Remission of sleep disturbances was associated with
better physical functioning (small effect size).
Compared with persistent poor sleepers, those whose
sleep improved had ‘some less’ physical limitation
than usual as indicated by an increase in PCS scores.
3) Integrated management and treatment of chronic pain
and insomnia may lead to better patient outcomes and
improvements not only in sleep quality and psycholog-
ical health status but also pain-related symptoms.
Research agenda
1) Experimental and longitudinal studies are needed to
verify the specific causal links between sleep, inflam-
matory processes, and the experience of pain.
2) Longitudinal studies with more than two follow-up as-
sessments and cross-lagged analysis are needed to sub-
stantiate the temporal relationship between changes in
sleep and pain outcomes and to provide a framework to
examine the trajectories of health status over time across
individuals with different patterns of sleep changes.
3) It would be desirable to further investigate the effec-
tiveness of interventions, e.g., cognitive behavioural
therapies, exercise programmes, medications, as
possible tools to enhance pain-related health outcomes
and quality of life via promoting sleep. This can serve as
further tests of the causal association between sleep,
pain, and wellbeing.
4) Subgroup analyses by phenotype (e.g., those in the
general population with chronic pain conditions, with or
without sleep problems) would help isolate factors
linked to the development, perpetuation, or alleviation of
pain experience. Knowledge of how sleep influences an
individual's pain experience may promote personalised
integrated interventions and management by sleep
phenotype.
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inclusion of studies with more than two assessment time-points,
only four studies would have met this requirement. This high-
lights the need for additional assessments for investigating the
temporal relationship between changes in sleep and pain outcomes
and for revealing the trajectories of health status over time within
groups of individuals with different patterns of sleep. Cross-lagged
analysis could be applied to these multi-wave data to establish
directions of causality [80].
Finally, the ﬁndings from these longitudinal studies were
mostly drawn from analyses at the general population level to
maximise generalisability. Future studies may beneﬁt from
incorporating subgroup analyses to dissect the sleep and pain
relationship, for example, through stratiﬁcation by age, by gender,
by those with malignant and non-malignant chronic pain condi-
tions, and by those with chronic pain but no sleep problems. This
would help reveal the context in which a change in sleep is a
contributing factor to the development, perpetuation, or allevia-
tion of these conditions. It would also provide new insights into
the potential of sleep as an amenable treatment target in the
management of these conditions across different spectra of the
population.
Limitations of the review
Some limitations in the present review and meta-analysis
should be acknowledged. First, the number of studies included in
the review and themeta-analysis was limited due to a lack of access
to required data and the stringent inclusion criteria. The results of
the meta-analysis should thus be considered as exploratory. That
said, the stringent inclusion criteria were necessary to capture only
studies with an appropriate longitudinal design that addresses and
analyses the effect of change in sleep on pain-related outcomes.
Second, the high level of heterogeneity observed in the analysis was
possibly due to variations in research methodologies, but the small
number of studies eligible for meta-analysis has made it impossible
to pin down the source of heterogeneity at this stage. Also, not all
studies assessed sleep in the same way despite having similar
outcome measures and there was consequently no consistent
deﬁnition of what denotes sleep stability, sleep deterioration and
sleep improvements.
Finally, as inherent in most systematic reviews, there is a risk of
publication bias although we found no obvious evidence of publi-
cation bias. The studies reviewed were limited to texts in English
even though studies included in the review involved cities/coun-
tries that are not English-speaking. There appeared to be no indi-
cation that cultural differences in pain reports distort the sleep-
pain association being examined. Nevertheless, future studies
should consider the possible inﬂuence of culture on the perception
of sleep and pain.
Conclusion
The current evidence provides moderate support that negative
changes in sleep have detrimental health effects and that
consistently good sleep favours better pain-related health out-
comes. Although there is emerging evidence for the relationship
between changes in sleep status and pain-related health out-
comes, full understanding of the mechanisms underlying the
causal relationship between sleep and pain remains incomplete.
In this review, improvements in sleep quantity and sleep quality
were not consistently associated with better health outcomes. The
jury is out regarding whether positive changes in sleep could lead
to a reduction of, or even full recovery from, pain symptoms.Please cite this article in press as: Afolalu EF, et al., Effects of sleep changes on pain-related health outcomes in the general population: A
systematic review of longitudinal studies with exploratory meta-analysis, Sleep Medicine Reviews (2017), http://dx.doi.org/10.1016/
j.smrv.2017.08.001
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